Pharmaceutical composition for treating gout and reducing urea acid and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for reducing uric acid and composition, which is applied in the field of pharmaceutical composition for treating gout and reducing uric acid. It can solve the problems of treating symptoms but not the root cause, toxic and side effects, and incomplete analgesia, and achieves good curative effect, short treatment period, and elimination of redness, swelling and pain. Effect
Inactive Publication Date: 2017-09-22
曹国荣
View PDF0 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0041] The purpose of the present invention is to provide a pharmaceutical composition that can not only eliminate redness, swelling and pain, but also reduce uric acid and treat gout and its preparation method, which overcomes the current chemical medicines and Chinese herbal medicines that treat gout by treating the symptoms but not the root cause, incomplete analgesia, and toxic side effects. Shortcomings
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0093] Pharmaceutical composition decoction of the present invention
[0094] Take the medicinal composition and add a constant amount of water to decoct, collect the infusion, add water and repeat the decoction, mix the infusion and bottle it, and take it twice a day after meals for gout patients.
Embodiment 2
[0096] Pharmaceutical composition oral liquid of the present invention
[0097] Take the medicinal composition and add a constant amount of water to decoct, collect the infusion, add water and repeat the decoction again, mix and concentrate the infusion, make oral liquid and bottle it as usual, and take it twice a day after lunch and dinner for gout patients.
Embodiment 3
[0099] Pharmaceutical composition capsule of the present invention
[0100]Take the medicinal composition and add a constant amount of water to decoct, collect the infusion, add water and repeat the decoction once, mix and concentrate the infusion to form an extract, granulate to 20 mesh, pack into capsules, and make capsules, each capsule is 0.4 grams, which is 10 grams of crude drug . Gout patients take it three times a day after meals, 10 capsules each time, and take it twice a day after meals, 15 capsules each time.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a pharmaceutical composition for treating gout and reducing urea acid and a preparation method thereof. The pharmaceutical composition is prepared from the following Chinese herbal medicines of vitex root, nodus pini, Chinese fir, radix scrophulariae, radix angelicae pubescentis, rhizoma seu radix notopterygii, radix gentianae macrophyllae, syngnathus, hippocampus, radix clematidis, poria cocos, semen coicis, pawpaw, radix achyranthis bidentatae, cortex acanthopanacis, herba taxilli and semen plantaginis. The pharmaceutical composition has the advantages that the decoction or ethyl alcohol (rice wine) extracting liquid (medicine wine) is used for treating gout; after three doses of pharmaceutical composition are orally administrated, the pain is relieved; after five doses of pharmaceutical composition are administrated, the pain is eliminated; after the pharmaceutical composition is continuously administrated for one month, the urea acid value is reduced to normal value, namely clinically healing; the medicine directly reaches focus of infection, so that the redness, swelling and pain of the focus of infection of the patient are eliminated, the urea acid is exhausted out of a human body, and the purpose of treating gout is realized; any obvious toxic or side effect is avoided; the defects of palliatives, unthorough pain relieving, and toxic or side effect in the existing gout treatment medicine are overcome.
Description
technical field [0001] The invention relates to a pharmaceutical composition for treating gout and reducing uric acid and a preparation method thereof. Background technique [0002] Gout is a recurrent attack caused by increased purine biosynthesis and metabolism, excessive uric acid production or poor excretion of uric acid, resulting in elevated uric acid in the blood and deposition of urate crystals in the synovium, synovial bursa, cartilage and other tissues Inflammatory diseases. It is a group of heterogeneous diseases caused by monosodium urate crystallization or supersaturation of uric acid in extracellular fluid, resulting in the deposition of crystals in tissues. The disease is characterized by birefringent sodium urate monohydrate crystals found in joint fluid and tophi. Its clinical features are: characteristic acute arthritis caused by hyperuricemia and urate crystals and deposits, tophi, interstitial nephritis, joint deformity and dysfunction in severe cases, ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more